Sponsor:
The Methodist Hospital Research Institute
Code:
NCT07948330
Conditions
Urinary Incontinence
Prostate Treatment
Incontinence After Prostate Treatment
Eligibility Criteria
Sex: Male
Age: 22 - 70+
Healthy Volunteers: Accepted
Interventions
Magstim - rTMS system
Baseline Imaging and Questionnaires
Brief summary:
Conditions
Urinary Incontinence
Prostate Treatment
Incontinence After Prostate Treatment
Study ID
NCT07948330
Start date
Sep 16, 2026
Status verified date
Nov, 2026
Completion date
Oct 1, 2027
Anticipated
Primary completion date
Oct 1, 2027
Anticipated
Eligibility Criteria
Sex: Male
Age: 22 - 70+
Healthy Volunteers: Accepted
Enrollment
23 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Other
Arms
experimental: High-Frequency rTMS (Excitatory)
experimental: Low-Frequency rTMS (Inhibitory)
other: Continent Controls
Interventions
Magstim - rTMS system
Baseline Imaging and Questionnaires
Primary outcome measure
Central contacts
Kelly Ieong, MD
kieong@houstonmethodist.orgLocations
Houston Methodist Hospital
Recruiting
Houston, Texas, United States, 77030
Contacts
Principal Investigator:
Rose Khavari, MD
Sponsor
The Methodist Hospital Research Institute
Last update posted
Nov 19, 2026
Last verified
Nov, 2026
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-11-20. This information was provided to ClinicalTrials.gov by The Methodist Hospital Research Institute on 2026-11-19. Recruitment status is synced daily from ClinicalTrials.gov and may not reflect the sponsor's current status. Confirm during your call.